PD-L1 served as a positive control in the screens because it mediates strong immune suppression in breast cancer (Dong et al, 2002) and in our assays PD-L1 knockdown increased CTL activity without intrinsic influence on tumor cell viability (Fig1C). Here, CD274 is linked to breast cancer.